REFERENCES
- Agarwal M, Ganesh S K, Biswas J. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome. Ocul Immunol Inflamm 2006; 14: 333–339
- Al Hemidan A I, Tabbara K F, Althomali T. Vogt-Koyanagi-Harada associated with diabetes mellitus and celiac disease in a 3-year-old girl. Eur J Ophthalmol. 2006; 16: 173–177
- Andreoli M C, Foster C S. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin 2006; 46: 111–122
- Bassili S S, Peyman G A, Gebhardt B M, Daun M, Ganiban G J, Rifai A. Detection of Ebstein-Barr virus DNA by polymerase chain reaction in the vitreous from a patient with Vogt-Koyanagi-Harada syndrome. Retina 1996; 16: 160–161
- Damico F M, Kiss S, Young L H. Vogt-Koyanagi-Harada disease. Semin Ophthalmol 2005; 20: 183–190
- Gruich M J, Evans O B, Storey J M, Bradley S T, Chen C J. Vogt-Koyanagi-Harada syndrome in a 4-year-old child. Pediatr Neurol 1995; 13: 50–51
- Ikeda N, Hayasaka S, Kadoi C, Nagaki Y. Vogt-Koyanagi-Harada syndrome in an 11-year-old boy. Ophthalmologica 1999; 213: 197–199
- Ohno S, Minakawa R, Matsuda H. Clinical studies of Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 1988; 32: 334–343
- Paredes I, Ahmed M, Foster C S. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy. Ocul Immunol Inflamm 2006; 14: 87–90
- Pras E, Neumann R, Zandman-Goddard G, et al. Intraocular inflammation in autoimmune diseases. Semin Arthritis Rheum 2004; 34: 602–609
- Rao N A. Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome. Eye 1997; 11: 213–216
- Rao N A. Treatment of Vogt-Koyanagi-Harada disease by corticosteroids and immunosuppressive agents. Ocul Immunol Inflamm 2006; 14: 71–72
- Rathinam S R, Vijayalakshmi P, Namperumalsamy P, Nozik R A, Cuningham E T. Vogt-Koyanagi-Harada syndrome in children. Ocul Immunol Inflamm 1998; 6: 155–161
- Rathinam S R, Namperumalsamy P, Nozik R A, Cunningham E T, Jr. Vogt-Koyanagi-Harada syndrome after cutaneus injury. Ophthalmology 1999; 106: 635–638
- Read R W, Rechodouni A, Butani N, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2001; 131: 599–606
- Read R W, Holland G N, Rao N A, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001; 131: 647–652
- Read R W, Yu F, Accorinti M, et al. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2006; 142: 119–124
- Sheu S J. Update on uveomeningoencephalitides. Curr Opin Neurol 2005; 18: 323–329
- Shindo Y, Inoko H, Yamamoto T, Ohno S. HLA-DRB1 typing of Vogt-Koyanagi-Harada disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol 1994; 78: 223–226
- Soheilian M, Aletaha M, Yazdani S, Dehghan M H. Management of pediatric Vogt-Koyanagi-Harada (VKH))-associated panuveitis. Ocul Immunol Inflamm 2006; 14: 91–98
- Tabbara K F, Chavis P S, Freeman W R. Vogt-Koyanagi-Harada syndrome in children compared to adults. Acta Ophthalmol Scand 1998; 76: 723–726
- Tugal-Tutkun I, Havrlikova K, Power W J, Foster C S. Changing patterns in uveitis of children. Ophthalmology 1996; 103: 375–383
- Tugal-Tutkun I, Ozyazgan Y, Akova Y A, et al. The spectrum of Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey. Int Ophthalmol Sep 7, 2006, (E-pub ahead of print)
- Yamaki K, Hara K, Sakuragi S. Application of revised diagnostic criteria for Vogt-Koyanagi-Harada disease in Japanese patients. Jpn J Ophthalmol 2005; 49: 143–148